Tempus to buy cancer test maker Personalis for $1.5 billion - Reuters
Tempus to buy cancer test maker Personalis for $1.5 billion Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOeDdaUjUzN3pPOUFOZFZnRDQtelVrYUFKcDFGZUxMXzhxVFlQejhnSWJ2b2VkM2h0YnRfRXJ6Qm0tMFQ5eWNLZW4yRncwZXVvN2dZWFE4LS02WkRuS2JiblQ0U3VVSm9jaGs5TjdtNnhzLXFBMUNuYXlUd2o0OGxwd0kzaVc3UUZ5QUJBQmpfVFNOSkN3c0RKcktoekRBMFJENEFBa0JranFHSjJs?oc=5" target="_blank">Tempus to buy cancer test maker Personalis for $1.5 billion</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMModerna shares double as cancer vaccine data rekindles investor hopes - Reuters
Moderna shares double as cancer vaccine data rekindles investor hopes Reuters
August 19, 2026 at 04:49 PMModerna, Merck breakthrough could usher in wave of cancer vaccines - Reuters
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
August 19, 2026 at 09:01 PMChip designer Velaura AI valued at more than $1 billion in funding round - Reuters
Chip designer Velaura AI valued at more than $1 billion in funding round Reuters
August 18, 2026 at 06:38 PMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMThoma Bravo to take Accelerant private in more than $4 billion deal - Reuters
Thoma Bravo to take Accelerant private in more than $4 billion deal Reuters
August 13, 2026 at 10:57 AM